SDHC:NYSESmith Douglas Homes Corp. Analysis
Data as of 2026-06-22 - not real-time
$13.75
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Smith Douglas Homes trades at $13.75, comfortably above its 20‑day ($12.85) and 50‑day ($13.10) moving averages but still below the long‑term 200‑day average ($16.28), signaling a short‑term bounce within a broader bearish backdrop. The RSI sits at 57.8, indicating neutral momentum, while the MACD line sits above its signal with a positive histogram, suggesting modest bullish pressure. However, the stock exhibits a steep 30‑day volatility of roughly 55 % and a beta above 1.3, underscoring heightened price swings relative to the market.
Fundamentally, SDHC reports an 8 % revenue decline, thin profit margins (0.9 % net), and a debt‑to‑equity ratio over 16×, raising solvency concerns despite a respectable ROE of 12.8 %. The forward PE of 22.2 is higher than the trailing 14.5, reflecting earnings pressure, while the DCF fair‑value estimate of $35.5 suggests the current price is modestly overvalued by about 2 %. The stock carries no dividend, the industry PE average sits near 32×, and the Fear & Greed Index shows “Extreme Greed,” hinting at potential market complacency.
Fundamentally, SDHC reports an 8 % revenue decline, thin profit margins (0.9 % net), and a debt‑to‑equity ratio over 16×, raising solvency concerns despite a respectable ROE of 12.8 %. The forward PE of 22.2 is higher than the trailing 14.5, reflecting earnings pressure, while the DCF fair‑value estimate of $35.5 suggests the current price is modestly overvalued by about 2 %. The stock carries no dividend, the industry PE average sits near 32×, and the Fear & Greed Index shows “Extreme Greed,” hinting at potential market complacency.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering above support at $11.13
- positive MACD histogram indicating short‑term momentum
- high 30‑day volatility may cause erratic moves
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- 8 % year‑over‑year revenue contraction
- debt‑to‑equity exceeding 16× raises leverage risk
- valuation near fair with DCF $35.5 versus market $13.75
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- cyclical real‑estate development exposure to interest‑rate cycles
- absence of dividend eliminates income component
- persistent earnings pressure and high leverage limit upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth-8.10%
Profit Margin0.90%
P/E Ratio14.5
ROE12.75%
ROA6.37%
Debt/Equity16.15
P/B Ratio1.5
Op. Cash Flow$3.9M
Free Cash Flow$25.7M
Industry P/E32.3
Technical Analysis
TrendBearish
RSI57.8
Support$11.13
Resistance$14.48
MA 20$12.85
MA 50$13.10
MA 200$16.28
MACDBullish
VolumeStable
Fear & Greed Index91.46
Valuation
Fair Value$35.51
Target Price$13.50
Upside/Downside-1.82%
GradeFair
TypeValue
Risk Assessment
Beta1.43
Volatility54.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.